November 19, 2019 MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers
January 16, 2019 MabPlex’s Manufactured Monoclonal Antibody Receives IND Approval from the U.S. Food and Drug Administration
May 30, 2018 MabPlex Announces the Opening of its San Diego, CA based Process Development Center of Excellence
